A Study to Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythaemia Patients
Clinical trial NCT06514807 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06514807
- Sponsor
- AOP Orphan Pharmaceuticals AG
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-04
- Primary completion
- 2028-03-15
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.